MedTrace Logo

To Study the Effects of Mango Ingestion in T2DM and Non-diabetic Subjects.

NCT06055582 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2023-09-26

No results posted yet for this study

Summary

T2DM patient will be recruited from endocrine OPD

1. Clinical History and Examination:

1. General Physical Examination:

* Height (cm)
* weight (kg)
* BMI (kg/m2)
* Blood Pressure (mmHg)
2. Anthropometry: Circumferences and skinfold thickness will be recorded for the patients in the following manner.

Circumferences:
* Waist circumference (cm)
* Hip circumference (cm)
* Mid-arm circumference (cm)
* Mid-thigh circumference (cm)
3. Skin fold thickness: Skin fold thickness will be measured by using (LANGE skin fold calipers) (to nearest of 1 mm) at the following sites

* Biceps (mm)
* Triceps (mm)
* Thigh (mm)
* Calf (mm)
* Sub scapular (mm)
* Supra-iliac (mm)
* Anterior axillary fold. (mm)
2. Biochemical Test: The biochemical analysis will be done using ELISA kit or commercially available kits

* Blood glucose (mg/dL)
* HbA1c (%)
* Serum insulin (μIU/mL)
* Total Cholestrol (mg/dl)
* Triglyceride (mg/dl)
* Fructosamine (umol/L)
* Adiponectin (µg/ml) -- HOMA-IR
3. Body Composition Analysis (TANITA)

Conditions

  • Normoglycemia
  • T2DM (Type 2 Diabetes Mellitus)

Interventions

DIETARY_SUPPLEMENT

Bread

81g (3 slices) harvest gold white bread as standard food.

DIETARY_SUPPLEMENT

Mango

250g of mango pulp of each mango variety was given to the subjects.

Sponsors & Collaborators

  • Indian Council of Medical Research

    collaborator OTHER_GOV

  • Diabetes Foundation, India

    lead OTHER

Principal Investigators

  • Anoop Misra, MD · Fortis CDOC Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-11
Primary Completion
2023-02-15
Completion
2023-03-01

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06055582 on ClinicalTrials.gov